Liver Cancer
Showing 1 - 25 of >10,000
Primary Liver Cancer Early Detection
Recruiting
- Liver Cancer
- Liver-cancer early detection test
-
Changchun, Jilin, China
- +1 more
Aug 10, 2023
Population in Improving Eearly Diagnosis Efficancy in Chinese
Recruiting
- Carcinoma, Hepatocellular
- +4 more
- Liver cancer surveillance every 3 months
- +2 more
-
Shanghai, Shanghai, ChinaDepartment of Infectious Diseases , Ruijin Hospital, Shanghai Ji
May 13, 2023
Liver Cancer Trial in Wuhan (Autologous Tumor Infiltrating Lymphocytes)
Recruiting
- Liver Cancer
- Autologous Tumor Infiltrating Lymphocytes
-
Wuhan, ChinaTongji Hospital
Oct 9, 2023
Liver Cancer, Liver Cirrhosis, Fatty Liver Trial in Guangzhou (Proteomics technology and liquid biopsy)
Recruiting
- Liver Cancer
- +3 more
- Proteomics technology and liquid biopsy
-
Guangzhou, Guangdong, ChinaSouthern medical university
Feb 8, 2023
Liver Cancer Trial in Zhuhai (No intervention)
Recruiting
- Liver Cancer
- No intervention
-
Zhuhai, Guangdong, ChinaZhuhai People's Hospital
May 14, 2023
Liver Cancer Risk Computation (LIRIC) Models
Active, not recruiting
- Predictive Cancer Model
- Liver Risk Computation Model (LIRIC)
- +2 more
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Nov 21, 2023
Recurrent Liver Cancer After Liver Transplantation Trial (Hepatic arterial infusion chemo + Atezolizumab and bevacizumab)
Not yet recruiting
- Recurrent Liver Cancer After Liver Transplantation
- Hepatic arterial infusion chemotherapy + Atezolizumab and bevacizumab
- (no location specified)
Apr 17, 2023
Liver Transplant Disorder, Hepatic Cancer Trial (assisted liver transplantation combined with two-stage hepatectomy)
Not yet recruiting
- Liver Transplant Disorder
- Hepatic Cancer
- assisted liver transplantation combined with two-stage hepatectomy
- (no location specified)
Mar 6, 2023
Depression, Anxiety, Liver Cancer Trial in Zhuhai (Cognitive behavioural therapy-based intervention, Educational group)
Not yet recruiting
- Depression
- +3 more
- Cognitive behavioural therapy-based intervention
- Educational group
-
Zhuhai, Guangdong, ChinaZhuhai People's Hospital
Jul 13, 2023
Cancer Liver, Cancer Head Neck Trial (Prehabilitation)
Not yet recruiting
- Cancer Liver
- Cancer Head Neck
- Prehabilitation
- (no location specified)
Mar 1, 2023
PDO/PDO-TIL/PDOTS for Drug Screen
Recruiting
- Liver Cancer
- Metastatic Liver Cancer
- Drug screen with PDO/PDO-TIL/PDOTS
-
Shanghai, Shanghai, ChinaZhongshan Hospital, Fudan University
Jun 13, 2023
Liver Transplant; Complications, Transplant; Failure, Liver, Transplant Dysfunction Trial (Liver transplantation)
Not yet recruiting
- Liver Transplant; Complications
- +6 more
- Liver transplantation
- (no location specified)
Jul 15, 2023
Carcinoma, Hepatocellular, Liver Cancer, Liver Cirrhosis Trial in United States (GALAD, Liver Ultrasound with or without AFP)
Not yet recruiting
- Carcinoma, Hepatocellular
- +3 more
- GALAD
- Liver Ultrasound with or without AFP
-
Los Angeles, California
- +9 more
Oct 18, 2023
Liver, Cancer of, Primary Resectable Trial in Guangzhou (Oxaliplatin, Doxorubicin, Lobaplatin)
Recruiting
- Liver, Cancer of, Primary Resectable
- Oxaliplatin
- +5 more
-
Guangzhou, Guangdong, ChinaZhujiang Hospital of Southern Medical University
Jan 18, 2023
Advanced Liver Cancer Trial (OH2 injection)
Not yet recruiting
- Advanced Liver Cancer
- OH2 injection
- (no location specified)
Jan 29, 2023
Liver Cancer, Radiofrequency Ablation, Esketamine Trial in Beijing (Dexmedetomidine-esketamine combination, Remifentanil,
Not yet recruiting
- Liver Cancer
- +3 more
- Dexmedetomidine-esketamine combination
- +2 more
-
Beijing, Beijing, ChinaPeking University First Hospital
Aug 19, 2023
Posto Perative Hepatocellular Carcinoma Trial (Neoantigen mRNA Personalised Cancer vaccine in combination with Stintilimab I
Not yet recruiting
- Posto Perative Hepatocellular Carcinoma
- Neoantigen mRNA Personalised Cancer vaccine in combination with Stintilimab I njection
- (no location specified)
Feb 27, 2023
Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT
Active, not recruiting
- Advanced Adult Primary Liver Cancer
- +3 more
- positron emission tomography
- computed tomography
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Nov 9, 2022
Hepatocellular Carcinoma Resectable Trial in Guangzhou (Oxaliplatin, Doxorubicin, Lobaplatin)
Recruiting
- Hepatocellular Carcinoma Resectable
- Oxaliplatin
- +5 more
-
Guangzhou, Guangdong, ChinaZhujiang Hospital of Southern Medical University
Mar 1, 2023
Liver Metastases, Liver Cancer, Liver Tumors Trial in Warsaw (PVE, LVD, ALPPS)
Not yet recruiting
- Liver Metastases
- +3 more
- PVE
- +2 more
-
Warsaw, Mazowieckie, PolandSecond Department of Clinical Radiology
Sep 17, 2023
Metastatic Liver Cancer Trial in Shanghai (HAIC?Bevacizumab?Camrelizumab)
Not yet recruiting
- Metastatic Liver Cancer
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Dec 7, 2022
Vascular Invasion Signatures in cfDNA Support Re-staging of
Completed
- Carcinoma, Hepatocellular
- +2 more
- Liver resection
-
Shanghai, Shanghai, ChinaEastern Hepatobiliary Surgery Hospital, Naval Medical University
Sep 15, 2022
Primary Liver Cancer Trial in Shanghai (Embosphere and chemo drug, Polyvinyl alcohol embolization microspheres (Huihe Medical)
Enrolling by invitation
- Primary Liver Cancer
- Embosphere and chemotherapy drug
- Polyvinyl alcohol embolization microspheres (Huihe Medical) and chemotherapy drug
-
Shanghai, Shanghai, ChinaShanghai Huihe Healthcare Tecnology Co.,Ltd.
Mar 5, 2023
Liver Cancer Trial in Hangzhou (3D Printed Model for preoperative planning)
Recruiting
- Liver Cancer
- 3D Printed Model for preoperative planning
-
Hangzhou, Zhejiang, China1# Banshan East Rd. Zhejiang cancer hospital
Aug 23, 2023
Hepatitis B Virus Reactivation:Cautionary Event After Liver
Completed
- Liver Transplant; Complications
- Diagnosis of postoperative recurrence of liver cancer
- (no location specified)
Oct 27, 2023